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Correlation of severity of chronic venous disease
with capillary morphology assessed by capillary
microscopy
Mohammad Hossain Howlader, MB BS, MD, and Philip D Coleridge Smith, DM,
London, United Kingdom
Background: In patients with lipodermatosclerosis caused by chronic venous disease of the lower limb, the skin capillaries
show proliferation and convolution. To our knowledge, no previous attempt has been made to correlate the clinical
severity of venous disease based on the CEAP classification with the capillary morphology changes. The purpose of this
study was to correlate the clinical severity with the capillary morphology changes in patients with chronic venous disease
by using capillary microscopy and to explore the significance of atypical capillary morphology in patients with
uncomplicated varicose veins.
Method: Patients attending the vascular clinic for management of chronic venous disease were examined clinically and by
duplex ultrasonography scans, and they were assigned to the appropriate CEAP clinical stage (C1, n  15; C2, n  20;
C3, n  15; C4a, n  15; C4b, n  15; C5, n  15). Also studied were 10 control subjects with no arterial or venous
disease of the lower limb. In part 1 of the study, a capillary microscope was used to obtain digital images of the skin
microcirculation in the gaiter region. The capillary density and capillary convolutions were counted in a 2.4 mm2 region
of skin. In part 2 of the study, a further 33 C2 and C3 patients were studied to provide more detailed information on a
small subgroup with unusual capillary morphology.
Results: In part 1 of the study, the capillary count was similar in controls and patients in CEAP stages C2 to C4a, but
decreased in patients of groups C4b and C5 (median count: C2, 15; C4b, 4; and C5, 7). The median number of the
capillary convolutions was 1 per capillary in patients of groups C1 to C3 and controls; C4a had 4 convolutions, C4b had
7, and C5 had >10. In part 2 of the study, an expanded group of 66 C2 and C3 patients was analyzed, of whom 14 had
a mean capillary loop count of more than two. Biologic markers of inflammation were investigated for their correlation
with capillary convolution, but no relationship was found.
Conclusions: Among patients with venous disease, increased capillary convolution is strongly associated with the more
severe stages (lipodermatosclerosis and healed ulceration). The significance of atypically increased capillary convolutions
in a small subgroup of C2/C3 patients remains unknown. (J Vasc Surg 2006;43:563-9.)The Edinburgh Vein Study found that varicose veins
are present in 40% of men and 32% of women, with skin
changes attributable to venous disease in 9% of men and 7%
of women.1 The center of the disease process in these cases
is the subpapillary capillary plexus in the skin.2 The micro-
circulation of the skin has been studied by histologic and
capillary microscopy during the last 20 years.3-7 Although
capillary microscopy has been used to assess the association
between the severity of venous disease assessed by Wid-
mer’s classification and nail fold changes,8 to our knowl-
edge, quantification of capillary morphologic changes in
the skin in the gaiter region of the leg has not been
reported. The aim of this study was to quantify changes in
the subpapillary capillaries by using capillary microscopy
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It has been suggested that cutaneous microangiopathy
precedes the development of trophic skin changes caused
by chronic venous disease and that the clinical degree of
skin change and the severity of microangiopathy are closely
related.3,7 It would therefore be beneficial to detect the
group of patients at risk of developing skin changes and
ulceration at the earliest possible stage. It would then be
possible to prioritize treatment to prevent further compli-
cations.
At present, there is no measure to indicate which of the
patients with uncomplicated varicose veins will develop skin
changes that might lead to ulceration. In a previous histo-
logic study, a small number of patients with uncomplicated
varicose veins showed proliferation of subpapillary capillar-
ies in a similar manner to those patients with more severe
venous disease.9 We hypothesized that these patients among
those with uncomplicated varicose veins (C2/C3) are at
risk of developing clinical skin changes. The aim of second
part of the study was to detect these patients and assess
whether they could be distinguished from other patients of
the same CEAP clinical stage by testing for biologic mark-
ers of inflammation that have previously been reported to
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venous disease10-12 and to symptoms of venous disease.
METHODS
Permission to conduct the study was obtained from
UCL Medical School Committee for Medical Ethics. Pa-
tients with chronic venous disease were recruited from the
vascular clinic at the Middlesex Hospital, and the controls
were healthy volunteers recruited from the staff and the
general public. A medical history was taken and a clinical
examination was performed. Patients who gave informed
written consent were studied further and were assigned to
the appropriate CEAP13 clinical stage by a surgeon experi-
enced in the management of venous disease (Table I).
All patients underwent a venous duplex examination to
establish venous reflux and to localize it anatomically. The
venous segments evaluated were the femoral, popliteal, and
deep veins of the calf (posterior tibial, peroneal, gastrocne-
mius). Reflux in any of these regions was classified as deep
vein incompetence. The great saphenous vein was evaluated
in the thigh and calf and the small saphenous vein in the
calf. Reflux in any of these segments was considered to be
superficial venous reflux (SSV).
Because we planned to use blood tests to assess systemic
inflammatory markers, we excluded those patients with
diseases likely to lead to elevation of biochemical markers of
inflammation not related to venous disease. Exclusion cri-
teria were patients treated for venous disease 3 months,
diabetes mellitus, any concomitant active disease, patients
treated with vasoactive drugs, deep venous thrombosis 12
months, superficial venous thrombosis 3 weeks, significant
peripheral vascular diseases (ankle-brachial pressure index
0.8), and infection or inflammation in the legs other than
that attributable to venous disease. Patients with leg ulcers
were also excluded.
In all, 192 patients were screened for this research, of
whom126 patients and 10 healthy volunteers drawn from
the staff of the department and patients with unrelated
disease were studied. Although this work was conducted
before the most recent revision of the CEAP classification
was published, we subdivided patients of CEAP clinical
stage C4 into C4a with hemosiderosis and venous eczema,
Table I. Clinical classification of lower limb chronic
venous disease13
C0 No visible or palpable signs of venous disease
C1 Telangiectases or reticular veins
C2 Varicose veins; distinguished from reticular veins
by a diameter of 3 mm or more
C3 Edema
C4 Changes in skin and subcutaneous tissue secondary
to chronic venous deficiency
C4a Pigmentation or eczema
C4b Lipodermatosclerosis or atrophie blanche
C5 Healed venous ulcer
C6 Active venous ulcerand C4b with lipodermatosclerosis. Our previous work hadsuggested that this division most accurately reflected the
clinical severity of venous disease.
We divided this work into two studies with different
aims. In the first part of the study, we analyzed the data
from groups of 15 to 20 patients taken from each of the
CEAP clinical stages C1 to C5. We also investigated
healthy control subjects who we considered to belong to
CEAP clinical stage C0. While conducting the first part of
the investigation, we found a small group of patients with
mild venous disease (CEAP clinical stages C2 and C3) who
appeared to have atypically increased capillary convolution.
We had observed similar findings in an earlier histologic
study.9
In the second part of the study, we recruited a larger
group of patients with mild venous disease to study this
phenomenon in more detail. In all, a further 28 patients in
stage C2 and three in stage C3 were included. Including
those patients already studied in part 1 of the investigation,
we had 66 patients with mild venous disease, 48 patients
with varicose veins (C2), and 18 patients with varicose veins
and edema (C3).
Part 1 procedure. The main part of this study was to
investigate the capillary circulation of the skin using a
capillary microscope. To minimize venous pressure in the
leg, subjects lay supine in an environmental chamber at
22°C. Patients and controls acclimatized for 10 to 20
minutes before the start of the experimental protocol. A
small amount of liquid paraffin was wiped over the exami-
nation area to minimize specular reflection from the skin
surface. In each patient and volunteer, the supramalleolar
skin 5 cm proximal to the medial malleolus or the region
most severely affected by lipodermatosclerosis in patients
with venous disease was investigated. At least four repre-
sentative areas of capillaries were studied in each limb.
We used a CAM1 Capillary Anemometer (KK Technology,
Devon, UK) capillary microscope with a high-resolution
(752  582 pixel) monochrome charge-coupled-device
video camera. Four ultra-bright light-emitting diodes epi-
illuminated the skin with a peak wavelength of 525 nm
(green). The microscope was attached to a heavy support to
allow it to be positioned on the skin in the gaiter region.
The microcirculation was viewed through a 10-mm diam-
eter acrylic disc placed in contact with the skin that pro-
vided mechanical stability to the microscope system. The
image was magnified6.3 to give an overall magnification
of about 1.23 m/pixel. The area of each microscope field
was 0.6 mm2.
Images were recorded at the time of the investigation
and stored on the computer disk drive as JPEG files. These
were analyzed at a later time to speed the investigation and
ensure that the author responsible for image analysis was
unaware of the clinical status of the volunteer from which
they came.
We assessed both the capillary density (number of
capillaries per unit area) and the complexity of the capillary
morphology. All clearly identifiable capillary loops in a field
were considered to be part of the total capillary count for
that area. These were considered to be visible capillaries.
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within the image, not all of the visible capillaries could be
evaluated for their morphology. Only those capillaries that
were clearly visible were considered to be evaluable. The
total number of visible capillaries was counted in a 2.4-mm2
region, where one field is 0.6 mm2. Within each capillary,
the number of convolutions was also counted. Capillary
density was expressed as the number of capillaries per mm2
area of skin. Morphology was assessed by counting the num-
ber of convolutions or loops per capillary. We counted a loop
as a 180° reversal of direction. The number of convolutions
for each evaluable capillary loop were counted, and when
more complex capillaries contained more than 10 loops,
they were recorded as 10. An average number of convo-
lutions per capillary were calculated for each patient based
on all evaluable capillary loops. We had established that this
method of quantification was reliable and reproducible in a
previous study.14
Part 2 procedure. In part 2, we identified a group of
patients with CEAP C2 and C3 stage venous disease, which
we defined as those with an average of more than two
convolutions per capillary. We considered that these were
the atypical group. Examples of capillary morphology
changes in various grades of CEAP clinical group are illus-
trated in Fig 1.
Patients assessed their symptoms of venous disease by
using a 10-cm-long visual analogue scale. The scale was
marked 0 to 10, severe symptoms were graded 10, and an
absence of symptoms was marked as 0. We inquired about
Fig 1. A, Simple loop capillaries (arrow) commonly seen in con-
trol subjects and in patients of CEAP clinical stages C1, C2, and
C3. B, This photograph shows early capillary convolutions with
variable number of loops (arrow) usually seen in C4a patients.
C, Photograph shows convoluted tortuous capillaries seen in
CEAP stages C4b and C5. D, Typical glomerulus-shaped cap-
illary seen in lipodermatosclerosis and healed ulceration (C4b
and C5). Here, the multiple proliferation of single capillary has
formed a “glomerulus.”pain, cramps, heaviness, paraesthesia, and edema. The dis-tance along the scale at which the patient placed a mark was
recorded in centimeters.
Hematologic tests were performed to assess systemic
inflammatory markers. A Butterfly 23-gauge canula (Veni-
systems, Abbott, Ireland) was placed in the distal long
saphenous vein or dorsal foot vein of the most affected leg
of the C2 and C3 patients. Five milliliters of blood was
collected into a citrated tube and 8 mL of blood was
collected into two Vacutainer tubes containing ethylene
diamine tetraacetic acid (Becton Dickinson Vacutainer Sys-
tems Europe, BP No 37-38241, Meylan Cedex, France).
Plasma from the samples was separated by centrifugation at
20,000 rpm for 10 minutes at 4°C within 1 hour of
collection and promptly frozen at –84°C before analysis of
enzyme-linked immunoabsorbent assay (ELISA).
Intercellular adhesion molecule-1 (ICAM-1) and vas-
cular cell adhesion molecule-1 (VCAM-1) were assayed
by using the commercially available kit manufactured by
Diaclone (Stamford, Conn). E-selectin, L-selectin, vascular
endothelial growth factor (VEGF) and the cytokines tumor
necrosis factor- (TNF-) and interleukin-6 (IL-6) were
measured by commercially available ELISA kits (R & D
Systems Europe, Abingdon UK) once all the samples were
collected. Von Willebrand factor was measured with the kit
manufactured by Shield Diagnostics, Aberdeen, UK. The
separate citrated samples were analyzed for leucocyte sur-
face CD11b and L-selectin expression by whole blood assay
using fluorescent-labelled monoclonal antibodies in a flow
cytometer.
Statistical analysis. Descriptors used to represent the
data are the median and interquartile ranges for the capil-
lary analysis and biologic markers. Differences between
medians were calculated by using the Wilcoxon method.
RESULTS
Table II summarizes the basic information concerning
Table II. Distribution of subjects according to age, sex,
and CEAP clinical stage
Stage
(n)
Sex
(F:M) Age*
SVI
(n)
DVI/SVI
(n)
Part 1
C0 (n  10) 6:4 43 (32-56)
C1 (n  15) 13:2 56 (53-61)
C2 (n  20) 14:6 53 (47-60) 16 4
C3 (n  15) 12:3 50 (41-59) 11 4
C4a (n  15) 5:10 52 (40-67) 8 7
C4b (n  15) 5:10 64 (55-68) 9 6
C5 (n  15) 5:10 50 (44-65) 7 8
Part 2 (after 28 C2 patients and 2 C3 patients were added)
C2 (n  48) 35:13 52 (44-59) 37 11
C3 (n  18) 15:3 52 (42-61) 14 4
Atypical
C2 (n  12) 7:5 56 (52-66) 10 2
C3 (n  2) 1:1 47 (44-50) 2 0
SVI, superficial venous insufficiency; DVI, deep venous insufficiency.
*Years (mean value) and range in parenthesis.the patients included in both parts of this study. The
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clinical stages, including that of the patients included in
part 2 of the study. The sex distribution was not equal in all
groups, however. In CEAP stages C1 to C3, the ratio of
female to male patients was 3.5:1, whereas in the C4a to C5
groups, it was 0.5:1. Because patients were recruited di-
rectly from an outpatient clinic, this distribution probably
reflects the referral pattern to our hospital. We suspect that
more women than men with less severe venous disease are
referred because this is partly a cosmetic problem as well as
resulting in symptoms. In the more severe stages, men
predominate, although there is no suggestion from epide-
miologic studies that this should be the case. Table II also
shows the duplex ultrasound findings, which have been
summarized in a simple way showing those with superficial
venous incompetence and those with combined deep and
superficial venous incompetence.
In patients with mild venous disease (CEAP C2 and
Fig 2. This graph shows the number of visible capillarie
are shown on the horizontal axis and the capillary densi
capillary density.
Fig 3. This graph shows the number of convolutions pe
bars represent the median value of each group.C3), superficial venous reflux alone was the most frequentfinding. In the more severely affected patients, approxi-
mately equal numbers of patients had isolated superficial
venous reflux and combined deep and superficial venous
reflux. Therefore, deep venous reflux was strongly associ-
ated with the more severe stages of venous disease. In view
of this uneven distribution of deep vein incompetence, we
considered that analysis of our measurements according to
whether there was deep or superficial venous reflux would
not lead to any useful conclusion. Of all the patients in-
cluded in our investigation, only three had an established
history of previous venous thrombosis. However, deep
venous thrombosis 1 year was an exclusion criterion for
patients in this study. In no patient was there duplex
ultrasound evidence of chronic obstruction of the deep
veins.
Table II also summarizes the data from the 66 patients
included in part 2 of the study. Here, 35 patients from part
1 of the study are combined with a further 31 C2 and C3
mm2 in the six CEAP stages studied. The CEAP stages
the vertical axis. The horizontal bar shows the median
illary on the vertical axis in six CEAP stages. Horizontals per
ty onr cappatients to investigate the phenomenon of atypical capillary
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of more than two convolutions per capillary.
Figs 2 and 3 show the results of the quantitative analysis
of the capillary morphologic changes. The capillary density
was similar in control patients and in those of CEAP clinical
stage C2 to C4a (Fig 2). Capillary density was reduced in
C4b and C5 patients, however. This corresponds to previ-
ous publications on this subject that have shown reduced
capillary density in patients with lipodermatosclerosis and
atrophie blanche. Capillary convolution (Fig 3) was identi-
cal in the C0 to C3 stages, with only one capillary loop seen
on average. Increased capillary convolution was seen in
patients of clinical stages C4a to C5, with the most severely
affected patients showing the greatest capillary convolu-
tion. Patients in the C1 group who had only telangiectases
and reticular veins showed no evidence of increased capil-
lary counts or convolution. Proliferation of vessels in these
patients was confined to much larger veins than were eval-
uated in this study.
In the second part of the study, the median number of
capillary convolutions was one (interquartile range [IRQ] 1
to 1.2) in the 52 patients without capillary convolution. In
the 14 patients with capillary convolution it was 3.1 (IQR
2.2 to 4.0), with a median difference of 2 (95% confidence
interval, 1.2 to 2.9, Wilcoxon method). The capillary den-
sity was identical in the two groups of patients evaluated in
part 2 of this investigation.
Table III. Association of inflammatory markers and symp
C
Number
Age
Inflammatory markers†
Neutrophil CD11b (FU)
Neutrophil CD62L (FU)
Monocytes CD11b (FU)
Monocytes CD62L (FU)
VEGF (pg/mL)
TNF- (pg/mL)
IL-6 (pg/mL)
sL-selectin (ng/mL) 1
sE-selectin (ng/mL)
sICAM-1 (ng/mL)
sVCAM-1 (ng/mL) 1
vWF (IU/mL)
Capillary microscopy
Capillary count
Symptoms recorded in cm on 10-cm visual analogue scale
Pain
Heaviness
Cramps
Paraesthesia
Edema
CI, Confidence interval; VEGF, vascular endothelial growth factor; TNF
molecule; sVCAM, soluble vascular adhesion molecule; vWF, von Willebran
*Median difference and 95% CI between “normal C2/C3 excluding atypic
supine. All data are median and inter-quartile ranges in parenthesis.
†CD62L values refer to down regulation.Table III compares the inflammatory mediators andsymptoms in the atypical group with the remainder of the
C2/C3 patients. For several of the inflammatory markers,
distinct differences are present between the control group
and the disease groups (data not shown). These included
increased levels of VEGF, IL-6, and soluble(s) L-selectin,
sICAM, and sVCAM in the venous disease patients com-
pared with control subjects. We found no difference be-
tween the atypical group and the remaining C2/C3 pa-
tients, however. Neither did symptoms recorded on the
visual analogue scale (VAS) differ between these groups.
DISCUSSION
The aim of this study was to quantify the morphologic
changes in the capillaries of the subpapillary plexus of skin
capillaries, which appear to be in the most severely affected
region of damage in patients with venous disease. We relied
on assessment of the capillary microscope images by an
experienced observer. This clearly has the possibility that
the outcome may be biased by the prejudice of the ob-
server, a problem which we investigated previously.14 We
found that there was excellent agreement between observ-
ers who made capillary counts and assessments of capillary
convolution. To minimize bias, we evaluated the capillaries
without the assessor being aware of the patient’s identity.
This allowed comparison between patients and assessment
of capillary morphology. We excluded images of poor
quality that were out of focus or in which no recognizable
with the groups of patients studied
3 excluding
ical group Atypical group
Median difference
(95% CI)*
52 14
41-59) 54 (51-65)
152-258) 137 (106-256) 20 (24 to 62)
64-53) 56 (60-53) 0 (4 to 5)
50-117) 86 (41-101) 5 (32 to 25)
46-30) 41 (42-34) 2 (8 to 11)
37-106) 60 (48-116) 12 (11 to 53)
0.6-9.2) 1.4 (.8-1.9) 0.5 (0.4 to 0.9)
1.3-2.8) 2.1 (1.4-2.9) 1 (0.7 to 0.5)
796-1202) 671 (612-915) 106 (274 to 69)
28-52) 46 (36-57) 4 (20 to 17)
394-630) 585 (442-701) 18 (129 to 24)
1039-1584) 1159 (868-1554) 2.5 (224 to 250)
1.0-1.6) 1.4 (1.2-1.8) 0.2 (0.5 to 0.1)
9-16) 16 (10-22) 3 (7 to 0)
1-4.9) 2.8 (0-5.4) 1.5 (2.9 to 0)
0-5) 1.9 (.1-4.6) 0 (1.9 to 1)
0-4.7) 3.2 (0-7) 1.95 (3.6 to 0)
0-2.8) 0 (0-0.2) 0 (0 to .5)
0-4.5) 0.8 (0-5) 0 (1.5 to 0.3)
or necrosis factor; IL, interleukin; sICAM, soluble intercellular adhesion
or.
d “atypical group” were calculated by using the Wilcoxon method. Patienttoms
2/C
atyp
51 (
202 (
58 (
79 (
38 (
104 (
1.3 (
2.2 (
052 (
39 (
547 (
270 (
1.3 (
12 (
3 (
3.5 (
2.5 (
0.3 (
0.7 (
, tum
d fact
al” ancapillaries could be found owing to the presence of large
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because of technical problems. In patients without obvious
skin changes, we used the supramalleolar skin proximal to
the medial malleolus; whereas in patients with skin changes,
the affected skin was assessed. Clearly, this may have led to
slightly different regions being investigated, but this is a
common strategy in studies of this type.15
Native capillaroscopy shows only the capillary loops
that are perfused or contain red blood cells. Not all capil-
laries are open at any time, and the count varies depending
on the circumstances of the observations. This can be seen
from a range of publications on capillary morphology
and density studies in chronic venous disease.16-19 We
concede that capillary counting does not count all capillar-
ies present, but we conducted this study under standard-
ized conditions that were the same for all subjects.
Despite our care in selecting well-defined clinical
groups, we found that although all CEAP stages contained
patients of similar age, there were far more women in the
less severe stages of venous disease (C1 to C3) and more
men in the more severe stages (C4 and C5). We acknowl-
edge that this may have led to some influence on the results;
however, we have been unable to find substantial differ-
ences between the capillary density and convolution in
patients of similar age but different gender.
Capillary density in the skin of patients with venous
disease has been investigated previously by a small number
of authors. It has previously been observed that capillary
density is reduced in those patients with the more severe
stages of venous disease, resulting in atrophie blanche and
lipodermatosclerosis.2,3 Our findings confirm these obser-
vations. We have shown that capillary density is broadly
similar in CEAP stages C0 to C4a but decreases in patients
of stages C4b and C5. Considerable overlap in the range of
capillary density was found between the different CEAP
stages, and therefore, reduced capillary density is not nec-
essarily a reliable predictor of the severity of the clinical
disease.
In contrast, capillary convolution was greatly increased
in the more severe CEAP clinical stages (C4a to C5) and
might be regarded as a strong indicator of disease severity.
The mean number of convolutions in mild stages of venous
disease (C1 to C3) is one per capillary loop, with very little
variation from this within capillaries from the same patient
and between capillaries from different patients. Increased
convolution was observed in patients of stage C4a, a group
where reduced capillary density has not been reported.
Therefore, the finding of increased capillary convolution
may be a more sensitive indicator than capillary density of
progression of microvascular injury in patients with venous
disease.
We recognize that assessment of capillary convolution
is a complex measure to use and is unlikely to be of
assistance in clinical practice. However, it may be useful in
research projects where the objective assessment of skin
changes is required in different patient groups and in re-
sponse to treatment. Capillary microscopy might avoid the
need to take skin biopsy specimens in some investigations.In part 2 of our study, we detected a small group of
patients in CEAP stages C2 and C3 that exhibited abnor-
mally increased convolution of their cutaneous capillaries in
the leg. Our definition of these skin changes was an average
number of convolutions greater than two per capillary loop.
Most patients had three to five convolutions per evaluable
capillary, but several had six to 10 convolutions per capil-
lary. The absolute numbers of patients identified with these
abnormalities in this study is small, only 14 patients of 66
C2 and C3 patients studied, or about 21%.
Varicose veins are present in 25% to 30% of the popu-
lation, but only 2% to 5% have skin changes or ulceration, a
proportion of 10% to 20%. We suspected that these patients
are prone to develop clinical skin changes and investigated
whether any of the inflammatory mediators that have pre-
viously been reported to be elevated in venous disease
differed between these patients and those without capillary
convolution. We were unable to find any difference be-
tween these groups during this investigation and acknowl-
edge that longitudinal studies would be required to answer
this question properly with groups of patients followed up
over many years.
When we commenced this investigation, the most re-
cent revision of the CEAP classification of venous disease
was still under discussion. Based on our earlier work, we
recognized that there were substantial differences between
patients with mild skin changes (eczema and hemosider-
osis) and those with atrophie blanche and lipodermatoscle-
rosis, both of which were classified as CEAP C4 under the
original system. We therefore divided these patients into
those with mild skin changes (C4a) and those with more
severe skin changes (C4b). The data reported here show
reduced capillary density in patients of C4b but not C4a
groups. In addition, the capillary convolution was greater
in C4b patients compared with C4a. We welcome the
international adoption of the revised CEAP classification in
which the differences between mild and more severe skin
changes are recognized.
The data we have presented show in which CEAP
stages the skin capillary changes are most severe. Clearly
many inflammatory processes are at work in the skin of
patients with lipodermatosclerosis and healed ulcers. The
considerable proliferation of cells and increased production
of collagen in these regions20 is an attempt at healing. It
could simply be the case that vascular proliferation is part of
this same process, arising in response to the development of
lipodermatosclerosis. However, we have also observed in-
creased capillary convolution in a small proportion of pa-
tients with apparently uncomplicated varicose veins and
have not found any patient with lipodermatosclerosis who
does not have capillary proliferation.
CONCLUSIONS
We have confirmed that reduced capillary density and
increased capillary convolution are features of the skin
changes that occur in chronic venous disease. We consider
that capillary convolution may be the more reliable indica-
tor of skin microangiopathy in venous disease and that it
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clinical trials. We have found that about one fifth of patients
with apparently uncomplicated venous disease (C2 and C3)
also show increased capillary convolution. Our present
study was unable to shed further light on this observation.
We suggest that this group may be more susceptible to
developing severe skin changes of venous disease than most
patients.
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